These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3913979)

  • 1. [Encephalopathy in patients treated by hemodialysis as a psychiatric problem].
    Pilaczyńska E
    Psychiatr Pol; 1985; 19(5):387-95. PubMed ID: 3913979
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
    Nielsen LP; Heaf JG
    Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
    [No Abstract]   [Full Text] [Related]  

  • 3. The dialysis encephalopathy syndrome. Possible aluminum intoxication.
    Alfrey AC; LeGendre GR; Kaehny WD
    N Engl J Med; 1976 Jan; 294(4):184-8. PubMed ID: 1244532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1 alpha(OH) vitamin D3 increases plasma aluminum in hemodialyzed patients taking Al(OH)3.
    Demontis R; Westeel PF; Boudalliez B; Moriniere P; Leflon A; Abdulmassih Z; Atik H; Renaud H; Fournier A
    Kidney Int Suppl; 1988 Mar; 24():S175-7. PubMed ID: 3163043
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal transplant to patients with latent or manifest dialysis dementia].
    Ricart MJ; Caralps A; Brulles A; Andreu J; Sola R; Oppenheimer F; Vilardell J
    Rev Clin Esp; 1982 Apr; 165(2):109-12. PubMed ID: 6750708
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain-aluminium concentration in dialysis encephalopathy.
    McDermott JR; Smith AI; Ward MK; Parkinson IS; Kerr DN
    Lancet; 1978 Apr; 1(8070):901-4. PubMed ID: 76845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of dialysis encephalopathy with deferoxamine].
    Starkstein S; Berthier M; Nogués M; Leiguarda R
    Medicina (B Aires); 1986; 46(3):327-31. PubMed ID: 3574092
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium carbonate: a suitable alternative to aluminum hydroxide as phosphate binder.
    Malberti F; Surian M; Colussi G; Poggio F; Minoia C; Salvadeo A
    Kidney Int Suppl; 1988 Mar; 24():S184-5. PubMed ID: 3163047
    [No Abstract]   [Full Text] [Related]  

  • 9. [Causes of hyperaluminemia in patients maintained on hemodialysis].
    Balezina OA; Ermolenko VM; Bel'skii NK; Nebol'sina LA; Segel'man VS
    Ter Arkh; 1982; 54(7):85-6. PubMed ID: 7135231
    [No Abstract]   [Full Text] [Related]  

  • 10. [EEG pattern indicative of dialysis encephalopathy].
    Dobato JL; Caminero AB
    Neurologia; 1999 Jan; 14(1):35. PubMed ID: 10079690
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenesis of dialysis encephalopathy.
    Arieff AI; Mahoney CA
    Neurobehav Toxicol Teratol; 1983; 5(6):641-4. PubMed ID: 6366603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The problem of the so-called dialysis encephalopathy].
    Both R; Mühlau G; Neumann J; Sperschneider H; Stein G
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():218-24. PubMed ID: 7157117
    [No Abstract]   [Full Text] [Related]  

  • 13. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
    Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
    Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
    [No Abstract]   [Full Text] [Related]  

  • 14. Aluminum in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminum compounds.
    Netter P; Kessler M; Burnel D; Hutin MF; Delones S; Benoit J; Gaucher A
    J Rheumatol; 1984 Feb; 11(1):66-70. PubMed ID: 6699835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum bone disease. (A case study).
    Coleman S
    J Nephrol Nurs; 1985; 2(3):125-6. PubMed ID: 3848476
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful treatment of progressive dialysis encephalopathy. Case report].
    Weiland P; Köhler M; Glatzel E
    Z Urol Nephrol; 1985 Jul; 78(7):387-93. PubMed ID: 4050157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminum binding to organic acids and plasma proteins. Implications for dialysis encephalopathy.
    Trapp GA
    J Environ Pathol Toxicol Oncol; 1985; 6(1):15-20. PubMed ID: 4067831
    [No Abstract]   [Full Text] [Related]  

  • 18. Accumulation of aluminum in a nondialyzed uremic child receiving aluminum hydroxide.
    Griswold WR; Reznik V; Mendoza SA; Trauner D; Alfrey AC
    Pediatrics; 1983 Jan; 71(1):56-8. PubMed ID: 6848980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudo-porphyria cutanea tarda in patients with chronic renal insufficiency and in patients with renal transplants].
    Antonello A; Peserico A; Corsano A; Zannini G; Fagiolo U
    Minerva Chir; 1980 May; 35(10):775-7. PubMed ID: 7005735
    [No Abstract]   [Full Text] [Related]  

  • 20. Dialysis encephalopathy: recovery after interruption of aluminium intake.
    Poisson M; Mashaly R; Lebkiri B
    Br Med J; 1978 Dec; 2(6152):1610-1. PubMed ID: 728750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.